Chemically defined generation of human cardiomyocytes

Existing methods for human induced pluripotent stem cell (hiPSC) cardiac differentiation are efficient but require complex, undefined medium constituents that hinder further elucidation of the molecular mechanisms of cardiomyogenesis. Using hiPSCs derived under chemically defined conditions on synthetic matrices, we systematically developed an optimized cardiac differentiation strategy, using a chemically defined medium consisting of just three components: the basal medium RPMI 1640, L-ascorbic acid 2-phosphate and rice-derived recombinant human albumin. Along with small molecule–based induction of differentiation, this protocol produced contractile sheets of up to 95% TNNT2+ cardiomyocytes at a yield of up to 100 cardiomyocytes for every input pluripotent cell and was effective in 11 hiPSC lines tested. This chemically defined platform for cardiac specification of hiPSCs will allow the elucidation of cardiomyocyte macromolecular and metabolic requirements and will provide a minimal system for the study of maturation and subtype specification.

[1]  Eric D. Adler,et al.  Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population , 2008, Nature.

[2]  Paul W. Burridge,et al.  Human Stem Cells for Modeling Heart Disease and for Drug Discovery , 2014, Science Translational Medicine.

[3]  Mohammad M. Karimi,et al.  Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells , 2013, Nature.

[4]  Yasuko Matsumura,et al.  A more efficient method to generate integration-free human iPS cells , 2011, Nature Methods.

[5]  P. Burridge,et al.  Improved Human Embryonic Stem Cell Embryoid Body Homogeneity and Cardiomyocyte Differentiation from a Novel V‐96 Plate Aggregation System Highlights Interline Variability , 2007, Stem cells.

[6]  S. Tsang,et al.  Differential gene expressions in atrial and ventricular myocytes: insights into the road of applying embryonic stem cell-derived cardiomyocytes for future therapies. , 2010, American journal of physiology. Cell physiology.

[7]  A. Folch,et al.  Human embryonic stem cell-derived cardiomyocytes migrate in response to gradients of fibronectin and Wnt5a. , 2013, Stem cells and development.

[8]  Geoffrey L. Francis,et al.  Albumin and mammalian cell culture: implications for biotechnology applications , 2010, Cytotechnology.

[9]  K. Chien,et al.  Long-term self-renewal of human pluripotent stem cells on human recombinant laminin-511 , 2010, Nature Biotechnology.

[10]  Olga K Afanasiev,et al.  Endogenous Wnt/β-Catenin Signaling Is Required for Cardiac Differentiation in Human Embryonic Stem Cells , 2010, PloS one.

[11]  Lila R Collins,et al.  Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts , 2007, Nature Biotechnology.

[12]  M. Suematsu,et al.  Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes. , 2013, Cell stem cell.

[13]  G E Moore,et al.  Culture of normal human leukocytes. , 1967, JAMA.

[14]  P. Doevendans,et al.  The human adult cardiomyocyte phenotype. , 2003, Cardiovascular research.

[15]  Wenqing Cai,et al.  Small molecule-mediated TGF-β type II receptor degradation promotes cardiomyogenesis in embryonic stem cells. , 2012, Cell Stem Cell.

[16]  Norio Nakatsuji,et al.  A small molecule that promotes cardiac differentiation of human pluripotent stem cells under defined, cytokine- and xeno-free conditions. , 2012, Cell reports.

[17]  Jing Zhang,et al.  Direct differentiation of atrial and ventricular myocytes from human embryonic stem cells by alternating retinoid signals , 2011, Cell Research.

[18]  Xuan Yuan,et al.  A Universal System for Highly Efficient Cardiac Differentiation of Human Induced Pluripotent Stem Cells That Eliminates Interline Variability , 2011, PloS one.

[19]  C. Mummery,et al.  Enhanced cardiomyogenesis of human embryonic stem cells by a small molecular inhibitor of p38 MAPK. , 2008, Differentiation; research in biological diversity.

[20]  B. Cui,et al.  Intracellular Recording of Action Potentials by Nanopillar Electroporation , 2012, Nature nanotechnology.

[21]  S. Kostin,et al.  Enhanced Connexin-43 and α-Sarcomeric Actin Expression in Cultured Heart Myocytes Exposed to Triiodo-l-thyronine , 2003, Journal of Molecular Histology.

[22]  M. Hasegawa,et al.  Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome , 2009, Proceedings of the Japan Academy. Series B, Physical and biological sciences.

[23]  L. V. Van Laake,et al.  Recombinant Vitronectin Is a Functionally Defined Substrate That Supports Human Embryonic Stem Cell Self‐Renewal via αVβ5 Integrin , 2008, Stem cells.

[24]  K. Tryggvason,et al.  Functional diversity of laminins. , 2012, Annual review of cell and developmental biology.

[25]  S. Baylin,et al.  Butyrate Greatly Enhances Derivation of Human Induced Pluripotent Stem Cells by Promoting Epigenetic Remodeling and the Expression of Pluripotency‐Associated Genes , 2010, Stem cells.

[26]  J. Kere,et al.  Clonal culturing of human embryonic stem cells on laminin-521/E-cadherin matrix in defined and xeno-free environment , 2014, Nature Communications.

[27]  J. Ouyang,et al.  Effects of triiodo-thyronine on angiotensin-induced cardiomyocyte hypertrophy: reversal of increased beta-myosin heavy chain gene expression. , 2006, Canadian journal of physiology and pharmacology.

[28]  K. Sekiguchi,et al.  Laminin E8 fragments support efficient adhesion and expansion of dissociated human pluripotent stem cells , 2012, Nature Communications.

[29]  Ernst J. Wolvetang,et al.  Microbioreactor Arrays for Full Factorial Screening of Exogenous and Paracrine Factors in Human Embryonic Stem Cell Differentiation , 2012, PloS one.

[30]  B. Cui,et al.  Iridium Oxide Nanotube Electrodes for Highly Sensitive and Prolonged Intracellular Measurement of Action Potentials , 2014, Nature Communications.

[31]  Gordon Keller,et al.  Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. , 2011, Cell stem cell.

[32]  Gregory J. Brewer,et al.  Survival and growth of hippocampal neurons in defined medium at low density: advantages of a sandwich culture technique or low oxygen , 1989, Brain Research.

[33]  J. Thomson,et al.  Embryonic stem cell lines derived from human blastocysts. , 1998, Science.

[34]  E. Stanley,et al.  A protocol describing the use of a recombinant protein-based, animal product-free medium (APEL) for human embryonic stem cell differentiation as spin embryoid bodies , 2008, Nature Protocols.

[35]  Sean P. Palecek,et al.  Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling , 2012, Proceedings of the National Academy of Sciences.

[36]  K. Clarke,et al.  Efficient differentiation of human induced pluripotent stem cells generates cardiac cells that provide protection following myocardial infarction in the rat. , 2012, Stem cells and development.

[37]  P. Doevendans,et al.  Patterning the heart, a template for human cardiomyocyte development , 2006, Developmental dynamics : an official publication of the American Association of Anatomists.

[38]  R. Passier,et al.  NKX2-5eGFP/w hESCs for isolation of human cardiac progenitors and cardiomyocytes , 2011, Nature Methods.

[39]  Shinya Yamanaka,et al.  Efficient and Scalable Purification of Cardiomyocytes from Human Embryonic and Induced Pluripotent Stem Cells by VCAM1 Surface Expression , 2011, PloS one.

[40]  A. G. Fadeev,et al.  Synthetic peptide-acrylate surfaces for long-term self-renewal and cardiomyocyte differentiation of human embryonic stem cells , 2010, Nature Biotechnology.

[41]  Liu Wang,et al.  Ascorbic acid enhances the cardiac differentiation of induced pluripotent stem cells through promoting the proliferation of cardiac progenitor cells , 2011, Cell Research.

[42]  Richard T. Lee,et al.  Ascorbic Acid Enhances Differentiation of Embryonic Stem Cells Into Cardiac Myocytes , 2003, Circulation.

[43]  A. Folch,et al.  Human Embryonic Stem Cell-Derived Cardiomyocytes Migrate in Response to Gradients of Fibronectin and Wnt 5 a , 2013 .

[44]  Gordon Keller,et al.  Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming. , 2012, Cell stem cell.

[45]  Jennifer M. Bolin,et al.  Chemically defined conditions for human iPS cell derivation and culture , 2011, Nature Methods.

[46]  G. Lyons,et al.  Extracellular Matrix Promotes Highly Efficient Cardiac Differentiation of Human Pluripotent Stem Cells: The Matrix Sandwich Method , 2012, Circulation research.

[47]  P. Mali,et al.  Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures , 2011, Cell Research.

[48]  A. F. Martin,et al.  Turnover of cardiac troponin subunits. Kinetic evidence for a precursor pool of troponin-I. , 1981, The Journal of biological chemistry.

[49]  J. Goh,et al.  Defining a threshold surface density of vitronectin for the stable expansion of human embryonic stem cells. , 2011, Tissue engineering. Part C, Methods.

[50]  T. Akaike,et al.  Culture of human pluripotent stem cells using completely defined conditions on a recombinant E-cadherin substratum , 2010, BMC Developmental Biology.